McKinsey Global Institute projected that broad GLP-1 adoption for eligible obese adults in high-income countries could generate USD 1.8 trillion in cumulative healthcare savings by 2040 through reduced cardiovascular hospitalizations, diabetes complication avoidance, and musculoskeletal disease prevention
Cell and tissue research, 377 (2), 153159
These statistics reveal a concerning risk-benefit ratio that doesn't support cosmetic use of IV glutathione
There was no difference in severe hypoglycaemia, genital candidiasis, acute pancreatitis, or gastrointestinal upset (nausea, vomiting and diarrhoea) between the two groups
More and more advertisements for weight loss medications are appearing in peoples daily lives
Platforms like Hims & Hers, Ro, Henry Meds, and others offer similar GLP-1 and HRT prescribing